Dr. Michael Zachariou has worked in Biotechnology for over 30 years, including for Bayer, Promega, Commonwealth Serum Laboratories and BioMarin Pharmaceutical. During that time he created and developed several key groups that have needed program or portfolio management systems. These have included systems for research facilities, CMO entities, a Global CMC Management organization and a Global Portfolio Management Office with several large portfolios, and oversight of hundreds of projects and strategic initiatives with a value exceeding $300m. Dr. Zachariou has been a member of several Research, Development and Manufacturing Leadership teams. He has also been a member of Internal Scientific Advisory Teams as well as advised Australian State and Federal governments on the Biotechnology Industry of that country.